1oi6

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Vancomycin, the last line of defense antibiotic, depends upon the, attachment of the carbohydrate vancosamine to an aglycone skeleton for, antibacterial activity. Vancomycin is a naturally occurring secondary, metabolite that can be produced by bacterial fermentation. To combat, emerging resistance, it has been proposed to genetically engineer bacteria, to produce analogues of vancomycin. This requires a detailed understanding, of the biochemical steps in the synthesis of vancomycin. Here we report, the 1.4 A structure and biochemical characterization of EvaD, an RmlC-like, protein that is required for the C-5' epimerization during synthesis of, dTDP-epivancosamine. EvaD, although clearly belonging to the RmlC class of, enzymes, displays very low activity in the archetypal RmlC reaction, (double epimerization of dTDP-6-deoxy-4-keto-D-glucose at C-3' and C-5')., The high resolution structure of EvaD compared with the structures of, authentic RmlC enzymes indicates that a subtle change in the enzyme active, site repositions a key catalytic Tyr residue. A mutant designed to, re-establish the normal position of the Tyr increases the RmlC-like, activity of EvaD.
+
Vancomycin, the last line of defense antibiotic, depends upon the attachment of the carbohydrate vancosamine to an aglycone skeleton for antibacterial activity. Vancomycin is a naturally occurring secondary metabolite that can be produced by bacterial fermentation. To combat emerging resistance, it has been proposed to genetically engineer bacteria to produce analogues of vancomycin. This requires a detailed understanding of the biochemical steps in the synthesis of vancomycin. Here we report the 1.4 A structure and biochemical characterization of EvaD, an RmlC-like protein that is required for the C-5' epimerization during synthesis of dTDP-epivancosamine. EvaD, although clearly belonging to the RmlC class of enzymes, displays very low activity in the archetypal RmlC reaction (double epimerization of dTDP-6-deoxy-4-keto-D-glucose at C-3' and C-5'). The high resolution structure of EvaD compared with the structures of authentic RmlC enzymes indicates that a subtle change in the enzyme active site repositions a key catalytic Tyr residue. A mutant designed to re-establish the normal position of the Tyr increases the RmlC-like activity of EvaD.
==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Amycolatopsis orientalis]]
[[Category: Amycolatopsis orientalis]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Merkel, A.B.]]
+
[[Category: Merkel, A B.]]
-
[[Category: Naismith, J.H.]]
+
[[Category: Naismith, J H.]]
[[Category: GOL]]
[[Category: GOL]]
[[Category: TMP]]
[[Category: TMP]]
Line 22: Line 22:
[[Category: vancomycin group antibiotic]]
[[Category: vancomycin group antibiotic]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 09:58:25 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:18:07 2008''

Revision as of 12:18, 21 February 2008


1oi6, resolution 1.40Å

Drag the structure with the mouse to rotate

STRUCTURE DETERMINATION OF THE TMP-COMPLEX OF EVAD

Overview

Vancomycin, the last line of defense antibiotic, depends upon the attachment of the carbohydrate vancosamine to an aglycone skeleton for antibacterial activity. Vancomycin is a naturally occurring secondary metabolite that can be produced by bacterial fermentation. To combat emerging resistance, it has been proposed to genetically engineer bacteria to produce analogues of vancomycin. This requires a detailed understanding of the biochemical steps in the synthesis of vancomycin. Here we report the 1.4 A structure and biochemical characterization of EvaD, an RmlC-like protein that is required for the C-5' epimerization during synthesis of dTDP-epivancosamine. EvaD, although clearly belonging to the RmlC class of enzymes, displays very low activity in the archetypal RmlC reaction (double epimerization of dTDP-6-deoxy-4-keto-D-glucose at C-3' and C-5'). The high resolution structure of EvaD compared with the structures of authentic RmlC enzymes indicates that a subtle change in the enzyme active site repositions a key catalytic Tyr residue. A mutant designed to re-establish the normal position of the Tyr increases the RmlC-like activity of EvaD.

About this Structure

1OI6 is a Single protein structure of sequence from Amycolatopsis orientalis with and as ligands. Known structural/functional Site: . Full crystallographic information is available from OCA.

Reference

The position of a key tyrosine in dTDP-4-Keto-6-deoxy-D-glucose-5-epimerase (EvaD) alters the substrate profile for this RmlC-like enzyme., Merkel AB, Major LL, Errey JC, Burkart MD, Field RA, Walsh CT, Naismith JH, J Biol Chem. 2004 Jul 30;279(31):32684-91. Epub 2004 May 24. PMID:15159413

Page seeded by OCA on Thu Feb 21 14:18:07 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools